Medical Director Structural Heart Program, Associate Professor of Medicine
University Of California Irvine
Orange, California, United States
Dr. Antonio Frangieh is an Associate Professor of Medicine, Interventional Cardiologist and Medical Director of the Structural Heart Program at the University of California Irvine School of Medicine.
He completed his fellowship in interventional cardiology at Zurich University Hospital in Switzerland, followed by fellowship training in structural heart interventions at the German Heart Center Munich, affiliated with the Technical University of Munich in Germany.
He is the author of many peer-reviewed articles and editorials published in prestigious medical journals, and also served as an international consultant and clinical proctor for transcatheter aortic, mitral and tricuspid valve therapies for the USA, Europe, China and MENA region.
He joined the University of California Irvine in July 2022 to lead their growing interventional and structural heart program.
Disclosure(s): Edward Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing)
Saturday, March 7, 2026
11:20 AM - 12:05 PM EST
Panel Discussion | Can We and Should We Skip TEE for LAA Closure? Role of CT and ICE?
Saturday, March 7, 2026
11:44 AM - 12:05 PM EST
EVOUQE | Update, Study and Post-Marketing Data
Saturday, March 7, 2026
10:57 AM - 11:05 AM EST
Panel Discussion | Are we Ready for Repair and Replacement of Tricuspid Disease?
Saturday, March 7, 2026
11:13 AM - 11:30 AM EST
Challenging Mitral TEER | When to Use Pascal Device
Saturday, March 7, 2026
2:32 PM - 2:40 PM EST
Panel Discussion | Finding the Suitable Patient for TEER
Saturday, March 7, 2026
2:48 PM - 3:10 PM EST
TAVR in Very Low EF Patients | Optimization, Device Choice and Procedural Strategy
Sunday, March 8, 2026
8:32 AM - 8:40 AM EST
Panel Discussion | What Do We Need to Know on Lifetime Management?
Sunday, March 8, 2026
9:20 AM - 9:40 AM EST
TEE Versus ICE Imaging for LAAC
Sunday, March 8, 2026
3:15 PM - 3:23 PM EST